N,N-Dimethyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrimidin-2-amine → N-(5-(3-(2-cyanopropan-2-yl)benzamido)-2-methylphenyl)-2-(2-(dimethylamino)pyrimidin-5-yl)thieno[2,3-b]pyrazine-6-carboxamide

HRID 1184835Notes

Reaction equation

HRID 1184835 reaction equation
[C:1]([C:3]([C:6]1[CH:7]=[C:8]([CH:37]=[CH:38][CH:39]=1)[C:9]([NH:11][C:12]1[CH:13]=[CH:14][C:15]([CH3:36])=[C:16]([NH:18][C:19]([C:21]2[S:35][C:24]3=[N:25][CH:26]=[C:27](C4C=NC=CC=4)[N:28]=[C:23]3[CH:22]=2)=[O:20])[CH:17]=1)=[O:10])([CH3:5])[CH3:4])#[N:2].[CH3:40][N:41]([CH3:57])[C:42]1[N:47]=[CH:46][C:45](B2OC(C)(C)C(C)(C)O2)=[CH:44][N:43]=1>>[C:1]([C:3]([C:6]1[CH:7]=[C:8]([CH:37]=[CH:38][CH:39]=1)[C:9]([NH:11][C:12]1[CH:13]=[CH:14][C:15]([CH3:36])=[C:16]([NH:18][C:19]([C:21]2[S:35][C:24]3=[N:25][CH:26]=[C:27]([C:45]4[CH:46]=[N:47][C:42]([N:41]([CH3:40])[CH3:57])=[N:43][CH:44]=4)[N:28]=[C:23]3[CH:22]=2)=[O:20])[CH:17]=1)=[O:10])([CH3:5])[CH3:4])#[N:2]

Participants

3

Reactant 2

HCID 16414215N,N-Dimethyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrimidin-2-amineHCID 86680167N-(5-(3-(2-cyanopropan-2-yl)benzamido)-2-methylphenyl)-2-(pyridin-3-yl)thieno[2,3-b]pyrazine-6-carboxamide

Product 1

HCID 54756425N-(5-(3-(2-cyanopropan-2-yl)benzamido)-2-methylphenyl)-2-(2-(dimethylamino)pyrimidin-5-yl)thieno[2,3-b]pyrazine-6-carboxamideYield 13%

Procedure

Preparation analogous to the synthesis of 25h by using 2-dimethylamino-pyrimidine-5-boronic acid pinacol ester (1.5 eq). Purified by HPLC to give the title compound N-(5-(3-(2-cyanopropan-2-yl)benzamido)-2-methylphenyl)-2-(2-(dimethylamino)pyrimidin-5-yl)thieno[2,3-b]pyrazine-6-carboxamide 25k (4 mg, 13%).

Workup

  1. customPreparation
  2. customPurified by HPLC

Sources & evidence

ORD record
ord-afd1c0c97ef847fd915dc813361b0d2d
Source dataset
uspto-grants-2014_03
Patent number
US08669256B2

Reaction notes

Loading…